INSMED INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
INSMED INC (INSM) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $16.15 per share as of 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2020-02-25
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $16.15.
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $15.90.
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $15.90.
- 2018-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $15.75.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2019-12-31 | $16.15 10-K · filed 2020-02-25 |
| 2018-12-31 | $15.90 10-K · filed 2020-02-25 |
| 2018-09-30 | $15.90 10-Q · filed 2018-10-30 |
| 2018-06-30 | $15.75 10-Q · filed 2018-08-02 |
| 2018-03-31 | $15.97 10-Q · filed 2018-05-02 |
| 2017-12-31 | $14.03 10-K · filed 2020-02-25 |
| 2017-09-30 | $13.88 10-Q · filed 2017-11-02 |
| 2017-06-30 | $13.82 10-Q · filed 2017-08-03 |
| 2017-03-31 | $13.32 10-Q · filed 2017-05-03 |
| 2016-12-31 | $13.25 10-K · filed 2019-02-22 |
| 2016-09-30 | $13.23 10-Q · filed 2016-11-03 |
| 2016-06-30 | $13.34 10-Q · filed 2016-08-04 |
| 2016-03-31 | $13.82 10-Q · filed 2016-05-05 |
| 2015-12-31 | $13.46 10-K · filed 2018-02-23 |
| 2015-09-30 | $13.38 10-Q · filed 2015-11-06 |
| 2015-06-30 | $13.32 10-Q · filed 2015-08-06 |
| 2015-03-31 | $11.33 10-Q · filed 2015-05-07 |
| 2014-12-31 | $10.32 10-K · filed 2017-02-23 |
| 2014-09-30 | $10.53 10-Q · filed 2014-11-06 |
| 2014-06-30 | $10.29 10-Q · filed 2014-08-06 |
| 2014-03-31 | $9.65 10-Q · filed 2014-05-08 |
| 2013-12-31 | $7.88 10-K · filed 2016-02-25 |
| 2013-09-30 | $7.33 10-Q · filed 2013-11-05 |
| 2013-06-30 | $6.62 10-Q · filed 2013-08-06 |
| 2013-03-31 | $4.72 10-Q · filed 2013-05-07 |
| 2012-12-31 | $4.11 10-K · filed 2015-02-27 |
| 2012-09-30 | $4.00 10-Q · filed 2012-11-07 |
| 2012-06-30 | $4.65 10-Q · filed 2012-08-07 |
| 2011-12-31 | $5.30 10-K · filed 2014-03-06 |
| 2010-12-31 | $18.43 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |